News

Panel recommends emergency authorization for molnupiravir oral capsules for COVID treatment in high-risk adults

The committee will discuss Emergency Use Authorization submitted by Merck & Co. Inc., for emergency use of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization.